Efficacy of FGFR Inhibitors and Combination Therapies for Acquired Resistance in FGFR2-Fusion CholangiocarcinomaMelanie A. Krook, Sameek Roychowdhury, John L. Hays et al.|Molecular Cancer Therapeutics|2020Cited by 138
Tumor heterogeneity and acquired drug resistance in FGFR2-fusion-positive cholangiocarcinoma through rapid research autopsyMelanie A. Krook, Sameek Roychowdhury, Dorrelyn M. Martin et al.|Molecular Case Studies|2019Cited by 88